Skip to content

Prospective Study of Deep Anterior Lamellar Keratoplasty Using Acellular Porcine Cornea

Prospective Study of Deep Anterior Lamellar Keratoplasty Using Acellular Porcine Cornea

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03105466
Enrollment
50
Registered
2017-04-10
Start date
2016-02-29
Completion date
2020-02-29
Last updated
2017-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corneal Transplantation

Keywords

Corneal Transplantation, Xenotransplantation, Bioegineered cornea

Brief summary

The performance of keratoplasty is hampered by the limited availability of donor cornea in many countries, especially in Asia. For this reason, attempts have been made to fabricate artificial substitutes for natural human cornea. So far, all polymeric biomaterials, such as collagen configurations and plastic compression, could mimic the functional optically transparent but failed to replicate the complicate three-dimension microstructure of natural cornea. Therefore, despite some favorable results yielded by polymeric biomaterials, they cannot be suited for long-term use. To overcome these disadvantages, in recent years, porcine cornea appeared specifically attractive for xenotransplantation, because of its accessibility and similarities to natural human cornea. However, xenotransplantation using fresh porcine cornea can occurs hyperacute immune rejection, resulting in graft failure. Such transplant rejection can be substantially lessened by using acellular porcine cornea (APC), which preserves the constructure of natural cornea, whilst having well biocompatibility and low antigenicity. These properties feature APC particularly suitable for high-risk keratoplasty, such as corneal grafting in infectious keratitis. Use of APC in LK has been shown promise in many preclinical animal studies and initially in human clinic trail. However, to optimize APC biological and biomechanical properties, the strategies for its preparation has evolved extensively over recent years, like various decellularization approaches (e.g. detergents, enzymes, human sera, hypertonic solutions and et al) and additional procedures (e.g. collagen re-crosslinking and repeated frozen-dry). Therefore, in the current study, the investigators analyzed the early surgical outcomes of deep anterior lamellar keratoplasty (DALK) using the APC that was very recently approved by the National Institutes for Food and Drug Control (NIFDC) of China for clinic practice, for management of infective keratitis, including fungal, viral and acanthamoeba keratitis. Here major concern of this study was to clarify the behavior of APC after implantation in participants.

Interventions

Deep anterior lamellar keratoplasty using acellular porcine cornea; 0.05%Tacrolimus eye drops, four times a day for at least one year; 0.3% Tobradex eyedrops, four times-one times a day for one year.

DEVICEAcellular Porcine Cornea
DRUGTobradex eyedrops

Sponsors

Zhongshan Ophthalmic Center, Sun Yat-sen University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

corneal diseases not involving the endothelial layer

Exclusion criteria

* corneal diseases involving the endothelial layer * allergic to pig tissue * do not accept xenotransplantation

Design outcomes

Primary

MeasureTime frame
the changes of Best corrected visual acuityBefore surgery, 1-week, 1-month, 3-month, 6-month, 1-year, 2-year, 3-year, 4-year after surgery

Secondary

MeasureTime frameDescription
the changes of visual contrast sensitivityBefore surgery, 3-month, 6-month, 1-year, 2-year, 3-year, 4-year after surgery
the changes in the transparency of graft1-week, 1-month, 3-month, 6-month, 1-year, 2-year, 3-year, 4-year after surgeryusing Slit lamp microscopic evaluation
The changes in corneal thickness depth1-week, 1-month, 3-month, 6-month, 1-year, 2-year, 3-year, 4-year after surgeryusing anterior segmental OCT
The changes in corneal nerve regeneration1-month, 3-month, 6-month, 1-year, 2-year, 3-year, 4-year after surgeryusing Confocal microscopy
The changes of depression and anxiety statusBefore surgery, 1-month, 3-month, 6-month, 1-year, 2-year, 3-year, 4-year after surgeryUsing Self-Rating Depression Scale (SDS) and Self-Rating Anxiaty Scale (SAS)

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026